1.
Fioretto P, Mauer M. Histopathology of diabetic nephropathy. Semin Nephrol 2007;27:195–207.CrossrefWeb of ScienceGoogle Scholar
2.
Liew BS, Perry C, Boulton-Jones JM, Simpson K, Paterson K. Diabetic nephropathy: An observational study on patients attending a joint diabetes renal clinic. Q J Med 1997;90:353–8.CrossrefGoogle Scholar
3.
Krolewski AS, Laffel LM, Krolewski M, Quinn M, Warran JH. Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med 1995;332:1251–5.Google Scholar
4.
Garcia MJ, McNamara PM, Gordon J, Kannel WB. Morbidity and mortality in diabetics in the Framingham population sixteen year follow-up study. Diabetes 1974;23:105–11.CrossrefGoogle Scholar
5.
Parving HH, Jacobsen P, Rossing K, Smidt UM, Hommel E, et al. Benefits of long term antihypertensive treatment on prognosis in diabetic nephropathy. Kidney Int 1996;49:1778–82.CrossrefGoogle Scholar
6.
Finne P, Reunanen A, Stenman S, Groop PH, Gronhagen-Riska C. Incidence of end-stage renal disease in patients with type 1 diabetes. J Am Med Assoc 2005;294:1782–7.Google Scholar
7.
Fathy MA, Elkady MM, Fathy HA, Awad SA, El menshawy AA. Estimation of renal tubular markers for predicting early stage diabetic nephropathy in Egyptian children with type I diabetes mellitus. Res J Med Med Sci 2009;4:207–11.Google Scholar
8.
MacIsaac RJ, Tsalamandris C, Panagiotopoulos S, Smith TJ, McNeil KJ, et al. Non albuminuric renal insufficiency in type 2 diabetes. Diabetes Care 2004;27:195–200.CrossrefGoogle Scholar
9.
Tolins JP, Shultz PJ, Raij L, Brown DM, Mauer SM. Abnormal renal hemodynamic response to reduced renal perfusion pressure in diabetic rats: role of NO. Am J Physiol 1993;265:F886–95.Google Scholar
10.
Mauer SM, Bilous RW, Ellis E, Harris R, Steffes MW. Some lessons from the studies of renal biopsies in patients with insulin-dependent diabetes mellitus. J Diabetes Complications 1988;2:197–202.CrossrefGoogle Scholar
11.
Parving HH, Mauer M, Ritz E. Diabetic nephropathy. In: Brenner BM, editor. Brenner & rector’s the kidney, 8th ed. Boston, MA: Saunders, 2008:1265–98.Google Scholar
12.
Gilbert RE, Cooper ME. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int 1999;56:1627–37.CrossrefGoogle Scholar
13.
Thomas MC, Burns WC, Cooper ME. Tubular changes in early diabetic nephropathy. Adv Chronic Kidney Dis 2005;12:177–86.Google Scholar
14.
Mason RM, Wahab NA. Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol 2003;14:1358–73.CrossrefGoogle Scholar
15.
Wolf G. Cell cycle regulation in diabetic nephropathy. Kidney Int Suppl 2000;77:59–66.CrossrefGoogle Scholar
16.
Pfleiderer S, Zimmerhackl LB, Kinne R, Manz F, Schuler G, et al. Renal proximal and distal tubular function is attenuated in diabetes mellitus type 1 as determined by the renal excretion of alpha 1-microglobulin and Tamm-Horsfall protein. Clin Investig 1993;71:972–7.CrossrefGoogle Scholar
17.
Yaqoob M, McClelland P, Patrick AW, Stevenson A, Mason H, et al. Evidence of oxidant injury and tubular damage in early diabetic nephropathy. QJM 1994;87:601–7.Google Scholar
18.
Chiarelli F, Cipollone F, Romano F, Tumini S, Costantini F, et al. Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration. Diabetes 2000;49:1258–63.CrossrefGoogle Scholar
19.
Savino A, Pelliccia P, Schiavone C, Primavera A, Tumini S, et al. Serum and urinary nitrites and nitrates and Doppler sonography in children with diabetes. Diabetes Care 2006;29:2676–81.CrossrefGoogle Scholar
20.
Komers R, Anderson S. Paradoxes of nitric oxide in the diabetic kidney. Am J Physiol Renal Physiol 2003;284:F1121–37.Google Scholar
21.
Platt JF, Rubin JM, Ellis JH, DiPetro MA. Duplex Doppler US of the kidney: Differentiation of obstructive from non obstructive dilatation. Radiology 1989;171:515–7.Google Scholar
22.
Platt JF, Ellis JH, Rubin JM. Intrarenal arterial Doppler sonography in the detection of renal vein thrombosis of the native kidney. Am J Roentgenol 1994;162:1367–70.Google Scholar
23.
Alter ML, Kretschmer A, Von Websky K, Tsuprykov O, Reichetzeder C, et al. Early urinary and plasma biomarkers for experimental diabetic nephropathy. Clin Lab 2012;58:659–71.Google Scholar
24.
Nielsen SE, Schjoedt KJ, Astrup AS, Tarnow L, Lajer M, et al. Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril. Diabet Med 2010;27:1144–50.CrossrefGoogle Scholar
25.
Lacquaniti A, Donato V, Pintaudi B, Vieste GD, Chirico V, et al. ‘‘Normoalbuminuric’’ diabetic nephropathy: tubular damage and NGAL. Acta Diabetol 2013;50:935–42.CrossrefGoogle Scholar
26.
Nielsen SE, Sugaya T, Hovind P, Baba T, Parving HH, et al. Urinary liver-type fatty acid-binding protein predicts progression to nephropathy in type 1 diabetic patients. Diabetes Care 2010;33:1320–4.Web of ScienceCrossrefGoogle Scholar
27.
Nielsen SE, Sugaya T, Tarnow L, Lajer M, Schjoedt KJ, et al. Tubular and glomerular injury in diabetes and the impact of ACE inhibition. Diabetes Care 2009;32:1684–8.CrossrefWeb of ScienceGoogle Scholar
28.
Marques-Vidal P, Ferrario M, Kuulasmaa K, Grafnetter D, Moltchanov V, for the WHO MONICA Project. Quality assessment of data on HDL cholesterol in the WHO MONICA Project (1999). Available from: URL:http://www.thl.fi/publications/monica/hdl/hdlqa.htm, URN:NBN:fi-fe19991137.
29.
Trivelli LA, Ranney HM, Lai HT. Hemoglobin components in patients with diabetes mellitus. N Engl J Med 1971;284:353–7.Google Scholar
30.
Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984;310:356–60.Google Scholar
31.
Youssef DM, Fawzy FM. Value of renal resistive index as an early marker of diabetic nephropathy in children with type-1 diabetes mellitus. Saudi J Kidney Dis Transpl 2012;23:985–92.Google Scholar
32.
Abd El Ghaffar S, El Kaffas K, Hegazy R, Mostafa M. Renal Doppler indices in diabetic children with insulin resistance syndrome. Pediatr Diabetes 2010;11:479–86.CrossrefGoogle Scholar
33.
Saif A, Soliman NA, Abdel-Hameed A. Early evaluation of renal hemodynamic alterations in type I diabetes mellitus with duplex ultrasound. Saudi J Kidney Dis Transpl 2010;21:295–9.Google Scholar
34.
Phillips AO. The role of renal proximal tubular cells I diabetic nephropathy. Curr Diab Rep2003;3:491–6.CrossrefGoogle Scholar
35.
Panduru Nm, Forsblom C, Saraheimo M, Thorn L, Bierhaus A, et al. Urinary liver-type fatty acid–binding protein and progression of diabetic nephropathy in type 1 diabetes. Diabetes Care 2013;36:2077–83.CrossrefGoogle Scholar
36.
Hovind P, Rossing P, Tarnow L, Johnson RJ, Parving HH. Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes an inception cohort study. Diabetes 2009;58:1668–71.CrossrefGoogle Scholar
37.
Mene P, Punzo G. Uric acid: by stander or culprit in hypertension and progressive renal disease? J Hypertens 2008;26: 2085–92.CrossrefWeb of ScienceGoogle Scholar
38.
Siu YP, Leung KT, Tong MK, Kwan TH. Use of allopurinol in slowing the progression of renal disease through its ability in lowering serum uric acid level. Am J Kidney Dis 2006;47: 51–9.CrossrefGoogle Scholar
Comments (0)